December 18, 2023 11:03 AM ESTUpdated December 19, 08:26 AM

First Wave to merge with ImmunogenX; Caliway raises $100M; New deals for Replay’s Syena

Kyle LaHucik

Senior Reporter

Ayisha Sharma

News Reporter

First Wave BioPharma’s merger plans: The Florida biotech said it plans to merge with ImmunogenX, another gastrointestinal diseases company that is …

Sign up to read this article for free.

Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.

BECOME A PREMIUM SUBSCRIBER

First Wave to merge with ImmunogenX; Caliway raises $100M; New deals for Replay’s Syena

Kyle LaHucik

Senior Reporter

Ayisha Sharma

News Reporter

Sign up to read this article for free.

Patient dies in Neurogene's Rett syndrome study

Lilly's board undergoes more changes; Merck strategy chief joins Roger Perlmutter at Eikon

Microsoft-backed Enveda raises $130M for drugs in I&I, obesity and other areas

RFK Jr. and Elon Musk want to ban pharma ads. They wouldn't be the first to try

AstraZeneca culls Phase 2 opioid use disorder drug

Are programs with compounded GLP-1s safe for your population?

First Wave to merge with Im­muno­genX; Cali­way rais­es $100M; New deals for Re­play’s Sye­na

Senior Reporter

News Reporter

Sign up to read this article for free.

First Wave to merge with ImmunogenX; Caliway raises $100M; New deals for Replay’s Syena